Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Randomized Elimination or Prolongation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Coronavirus Disease 2019

NCT04338009 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT04338009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04338009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Randomized Elimination or Prolongation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Coronavirus Disease 2019
Lead sponsor
University of Pennsylvania
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2020
Completion date
August 20, 2020
Enrollment
152 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19